Prediction of Hospitalization Stay in COPD Exacerbations: The AECOPD-F Score

BACKGROUND: Hospital admissions for COPD exacerbations account for 70% of total costs of COPD treatment, and the duration of hospital stay is directly related to this cost. The aim of this study was to investigate possible associations of demographic, clinical, laboratory, and functional parameters with stay of subjects admitted for COPD exacerbations and to provide a score for the prediction of the need for prolonged hospitalization. METHODS: We included 164 consecutive subjects admitted to 2 respiratory medicine departments of 2 tertiary hospitals for a COPD exacerbation, and we evaluated laboratory, clinical, and functional parameters possibly related to the duration of hospital stay. RESULTS: Seven parameters evaluated on subject admission (Antonisen type of exacerbation, number of Exacerbations in the previous year, Charlson index of comorbidities, Oxygenation, Partial pressure of PaCO2 in arterial blood gases, Dyspnea according to the Borg dyspnea scale, and history of chronic respiratory Failure) were able to predict stay and were included in a simple score named AECOPD-F. The area under the curve of the score for the prediction of prolonged hospital stay is 0.960, and a cutoff point ≥ 3 predicts prolonged stay with a sensitivity of 84.5% and a specificity of 92.5% (95% CI 0.917–0.984). The AECOPD-F score was validated in a second group of 88 subjects admitted to the hospital for a COPD exacerbation. In the validation group, subjects with a score ≥ 3 required prolonged stay compared with those with a score < 3 (8.0 [6.0–10.0] vs 6.5 [4.0–9.0] d, respectively, P = .007). CONCLUSION: The AECOPD-F score could accurately predict stay in hospitalized COPD subjects. The implementation of this score in clinical practice could be useful in the discharge planning of such subjects.

[1]  M. Pearson,et al.  Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease , 2002, Thorax.

[2]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[3]  A. Agustí,et al.  Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD. , 2001, The European respiratory journal.

[4]  A I Mushlin,et al.  The necessary length of hospital stay for chronic pulmonary disease. , 1991, JAMA.

[5]  J. Peters,et al.  Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional study , 2012, BMJ Open.

[6]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[7]  G. Borg Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.

[8]  W. Banya,et al.  The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations , 2012, European Respiratory Journal.

[9]  A. Sierra,et al.  Factores predictivos de un ingreso corto en pacientes con enfermedad pulmonar obstructiva crónica agudizada , 2005 .

[10]  N. Roche,et al.  Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome , 2010, Current opinion in pulmonary medicine.

[11]  S. Bourke,et al.  Predicting outcomes following hospitalization for acute exacerbations of COPD. , 2010, QJM : monthly journal of the Association of Physicians.

[12]  N. Siafakas,et al.  Prevalence of COPD in Greece. , 2004, Chest.

[13]  D. Sin,et al.  Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. , 2008, Canadian respiratory journal.

[14]  C. Roussos,et al.  Predictors of Outcome After Exacerbation of Chronic Obstructive Pulmonary Disease , 2009, Journal of General Internal Medicine.

[15]  N. Roche,et al.  Predictors of outcomes in COPD exacerbation cases presenting to the emergency department , 2008, European Respiratory Journal.

[16]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[17]  A. de la Sierra,et al.  [Factors predicting a short length of stay for acute exacerbations of chronic obstructive pulmonary disease]. , 2005, Medicina clinica.

[18]  H. Reddel,et al.  American Thoracic Society , 2001 .

[19]  J. Soriano,et al.  Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. , 2012, Chest.

[20]  T. Keistinen,et al.  Impact of comorbidities on the duration of COPD patients' hospital episodes. , 2003, Respiratory medicine.

[21]  C. Bucknall,et al.  Early discharge for patients with exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial , 2000, Thorax.

[22]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[23]  S Pita,et al.  Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease , 2002, Journal of internal medicine.

[24]  M. Pahor,et al.  Predicting length of stay of older patients with exacerbated chronic obstructive pulmonary disease , 2001, Aging.

[25]  R. Altın,et al.  Clinical Factors Affecting the Direct Cost of Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2012, International journal of medical sciences.

[26]  S. Sullivan,et al.  The costs of treating COPD in the United States. , 2001, Chest.

[27]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[28]  R. Levy,et al.  Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. , 2009, Canadian respiratory journal.

[29]  O. V. van Schayck,et al.  Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial , 2012, BMJ Open.

[30]  A. Anzueto,et al.  Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. , 2012, Respiratory medicine.

[31]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .

[32]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[33]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[34]  T. Ng,et al.  Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. , 2007, Archives of internal medicine.

[35]  M J Connolly,et al.  Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation , 2006, Thorax.

[36]  R M Angus,et al.  “Hospital at home” versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial , 2000, BMJ : British Medical Journal.

[37]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.